TSE News

Decision on Delisting, etc. - Mebiopharm Co.,Ltd. -

Update : May 10, 2013

print

[Tokyo Stock Exchange, Inc.]

Delisting of the following issue has been determined and it has been designated as Securities to Be Delisted.

1. Delisting and Designation as Securities to Be Delisted

(1) Issue Mebiopharm Co.,Ltd. stock
(Code: 4580, Market: TOKYO PRO Market)
(2) Securities to Be Delisted    Designation Period From May 10, 2013 (Fri.) to Jun. 06, 2013 (Thu.)
(3) Delisting Date Jun. 07, 2013 (Fri.)
(Note) In cases where any event requiring prompt delisting occurs, TSE may change the above designation period and delisting date.
(4) Provision Special Regulations of Securities Listing Regulations Concerning
Specified Listed Securities Rule 143
(5) Reason Due to submission of delisting application by Mebiopharm Co.,Ltd. today and determination of delisting by TSE.

2. Exclusion from Securities in Lieu of Money

Stocks of the same company will be excluded from securities in lieu of money for the following items from May 13, 2013 (Mon.) inclusive.
- Customer margin for margin trading and when-issued transactions
- Trading margin for when-issued transactions
- Trading participant security money
- Participant bond

DISCLAIMER: This translation may be used only for reference purposes. This English version is not an official translation of the original Japanese document. In cases where any differences occur between the English version and the original Japanese version, the Japanese version shall prevail. Tokyo Stock Exchange, Inc. and/or Tokyo Stock Exchange Regulation shall individually or jointly accept no responsibility or liability for damage or loss caused by any error, inaccuracy, or misunderstanding with regard to this translation.

Contact

Tokyo Stock Exchange, Inc.
Listing Department
Listed Company Services
Tel: +81-3-3666-0141

Top of Page